<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药筛 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T20:27:30+08:00</updated>
  <subtitle>药品筛选</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>百亿PPI市场，集采后会怎样？</title>
    <updated>2020-11-05T19:36:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/uFEmgFdIARWrThLt_V9l0g</id>
    <link href="https://mp.weixin.qq.com/s/uFEmgFdIARWrThLt_V9l0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>97个品种过评，注射剂过评通道开放 | 10月仿制药动态</title>
    <updated>2020-11-04T10:17:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/HaDTF-zvPWD4cBjPRzaI2g</id>
    <link href="https://mp.weixin.qq.com/s/HaDTF-zvPWD4cBjPRzaI2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些注射剂总销售额过千亿，离集采还有多远</title>
    <updated>2020-11-03T18:11:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/-qSuofgS1izeYzN-0upj_g</id>
    <link href="https://mp.weixin.qq.com/s/-qSuofgS1izeYzN-0upj_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注射用硼替佐米 齐鲁、豪森过评价 | 上周仿制药动态（10.26-11.1）</title>
    <updated>2020-11-02T20:32:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/iHCSmgmtkOMMDzS3n1pRUw</id>
    <link href="https://mp.weixin.qq.com/s/iHCSmgmtkOMMDzS3n1pRUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注射剂一致性评价补充申请通道打开，价格大战近在眼前</title>
    <updated>2020-10-29T18:33:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/NMaRY7psUg8SzP4X7nvq-g</id>
    <link href="https://mp.weixin.qq.com/s/NMaRY7psUg8SzP4X7nvq-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>依诺肝素、美罗培南、帕瑞昔布3个注射剂过评 | 上周仿制药动态（9.19-10.25）</title>
    <updated>2020-10-26T17:26:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/A6gvUi_dkdsqKVoPWI01FQ</id>
    <link href="https://mp.weixin.qq.com/s/A6gvUi_dkdsqKVoPWI01FQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这个最强乙肝药，还能入手不？</title>
    <updated>2020-10-24T09:03:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/8o5VUQTRaHp-hQtwXEE9nQ</id>
    <link href="https://mp.weixin.qq.com/s/8o5VUQTRaHp-hQtwXEE9nQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物港股上市在即，又一100亿+市值创新药公司来了</title>
    <updated>2020-10-21T17:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/QFvcRnjAU-Q-IXo57dGFEQ</id>
    <link href="https://mp.weixin.qq.com/s/QFvcRnjAU-Q-IXo57dGFEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚CDE发文：注射剂一致性评价，不二次发补！实质缺陷，不批！</title>
    <updated>2020-10-21T17:59:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-21:/s/GX2HIPgb90eQQE57WaMZwA</id>
    <link href="https://mp.weixin.qq.com/s/GX2HIPgb90eQQE57WaMZwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华海药业 净利润大增64%，销售费用降31%</title>
    <updated>2020-10-20T18:45:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/AfL35MAKNX5oYBYRuTBaSg</id>
    <link href="https://mp.weixin.qq.com/s/AfL35MAKNX5oYBYRuTBaSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>丽珠制药 亮丙瑞林微球一致性评价申报 | 上周仿制药动态（9.12-10.18）</title>
    <updated>2020-10-19T19:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/V1Rh1usd7xteDCZXVl2D1A</id>
    <link href="https://mp.weixin.qq.com/s/V1Rh1usd7xteDCZXVl2D1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>